Cetuximab and Dasatinib in Recurrent Squamous Cell Carcinoma
Clinical trial NCT01488318 · TERMINATED
Trial details
- NCT number
- NCT01488318
- Sponsor
- Julie E. Bauman, MD, MPH
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-09-01
- Primary completion
- 2016-01-01
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.